Suzette Delaloge

37PUBLICATIONS
285CO-AUTHORS
Molecular targetsLiquid biopsiesDisease surveillancePredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Sep 21, 2026
Safety and Efficacy of Ceralasertib plus Olaparib for Advanced/Metastatic Triple-Negative Breast Cancer in Three Molecular Strata: The Phase II VIOLETTE Study.

|Apr 17, 2026
Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial.

|Sep 23, 2025
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Séverine Guiu, Judith Balmaña, Pablo Lemercier

|Aug 30, 2025
Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians.

Elie Rassy, Suzette Delaloge, Yannis Slaouti

|Jul 29, 2025
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers.

Roman M Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki

|Jul 02, 2025
Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides.

I Garberis, V Gaury, C Saillard

Pageof 7

Frequent Collaborators

10 joint publications

Barbara Pistilli

7 joint publications

Fabrice André

6 joint publications

Stefan Michiels

5 joint publications

Ines Vaz-Luis